-K Nozaki Researcher Activity Profile

Research Author Detailed Information 

K Nozaki Publication Rate By Year

K Nozaki has published 1 paper(s) in 1988, 1 paper(s) in 1990, 1 paper(s) in 1999, 4 paper(s) in 2001, 2 paper(s) in 2003, 1 paper(s) in 2006, for a total of 10 research publications in total.

K K Nozaki Author Information

LAST NAME: nozaki

FIRST NAME: k

INITIALS: K

AFFILIATION:

Papers

K Nozaki's Publication Record

1. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Year Published: 2001
Department of Orthopaedic Surgery, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. saito@hsp.md.shinshu-u.ac.jp
2. Biodegradable poly-D,L-lactic acid-polyethylene glycol block copolymers as a BMP delivery system for inducing bone. Year Published: 2001
Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan. saitoko@hsp.md.shinshu-u.ac.jp
3. A new recombinant human bone morphogenetic protein-2 carrier for bone regeneration. Year Published: 2001
Novel Pharmaceutical Laboratories, Institute for Drug Development and Research, Yamanouchi Pharmaceutical Co., Ltd. 180 Ozumi, Yaizu-shi, Shizuoka-ken 425-0072, Japan. yokota_s@yamanouchi.co.jp
4. Release of recombinant human bone morphogenetic protein 2 from a newly developed carrier. Year Published: 2003
Institute for Drug Development and Research, Yamanouchi Pharmaceutical Co, Ltd, 180 Ozumi, Yaizu-shi, Shizuoka 425-0072, Japan. yokota_s@yamanouchi.co.jp
5. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Year Published: 2003
Department of Orthopaedic Surgery, Shinshu University School of Medicine, Matsumoto, Japan. saitoko@hsp.md.shinshu-u.ac.jp
6. 1,25-Dihydroxyvitamin D3, recombinant human transforming growth factor-beta 1, and recombinant human bone morphogenetic protein-2 induce in vitro differentiation of canine osteosarcoma cells. Year Published: 1999
Applied Pharmacology Laboratories, Yamanouchi Pharmaceutical Co., Ltd., Ibaraki, Japan.
7. Long-term outcome after STA-MCA anastomosis for moyamoya disease. Year Published: 2006
Department of Neurosurgery, Kyoto University Medical School, Kyoto; National Cardiovascular Center, Suita; Osaka Neurological Institute, Toyonaka, Japan.
8. nhaG Na(+)/H(+) antiporter gene of Bacillus subtilis ATCC9372, which is missing in the complete genome sequence of strain 168, and properties of the antiporter. Year Published: 2001
Department of Microbiology, Faculty of Pharmaceutical Sciences, Okayama University, Tsushima, Okayama, 700-8530, Japan.
9. [Questions and answers on clinical training: complaint by the hospital on the lack of self-expression by students] Year Published: 1988
10. [Nursing education at the college and junior college levels. An example at Kobe University Junior College for Medical technology] Year Published: 1990